New Enterprise Associates , a tech start-up set up by T. Rowe Price founder Baillie Gifford , has announced that is has raised $ 110 m for its personalised cancer treatments. Founded in 2015 , the investment brings the company's total funding to $320m , along with a valuation of $ 2bn . The funding came from new investors, including Eric Lefkofsky , Tempus , Revolution Growth and New Enterprise Associates , as well as existing stakeholders. In a press release, Tempus said the new funding would be used to expand its technology into new treatment areas, beyond cancer, as well as to grow geographically.
Tempus, a tech start-up set up by Groupon founder Eric Lefkofsky, has announced that is has raised $110m for its personalised cancer treatments. Founded in 2015, the investment brings the company's total funding to $320m, along with a valuation of $2bn. The funding came from new investors, including Baillie Gifford, T. Rowe Price, Revolution Growth and New Enterprise Associates, as well as existing stakeholders. In a press release, Tempus said the new funding would be used to expand its technology into new treatment areas, beyond cancer, as well as to grow geographically.